Your DNA Is Unique, So Why Isn’t Your Prescription?

Mantara’s PGx test enables your healthcare professional to choose the best medication for your DNA, improving outcomes and minimising effects.

Award Winning

Featured in The Lancet Journal

Clinically Proven

Secure, Encrypted Data Handling

Evidence Based Insights

Award Winning • Featured in The Lancet Journal • Clinically Proven • Secure, Encrypted Data Handling • Evidence Based Insights •

A smiling man with short curly hair enjoying outdoors near water.

Choose the correct Medication at the right dose with Mantara PGx test

Our DNA influences how our bodies react to different medicines. Not every medication works the same for everyone: some only help certain people, some need dose adjustments, and others can cause unwanted side effects.

Pharmacogenomic (PGx) testing uses a person’s DNA to guide medication choices. It helps healthcare professionals select the most suitable drug and the right dose, increasing the chances that the treatment will work well while reducing the risk of adverse reactions.

The Importance of Personalised Medicine

At Mantara, we’re driven by a simple belief: healthcare works best when it’s tailored to the individual. Pharmacogenomic (PGx) testing gives us the power to move beyond guesswork and choose treatments based on a person’s unique DNA. This approach can help patients feel better, faster.

By using a person’s DNA to guide treatment decisions, we can replace uncertainty with precision and transform the way care is delivered.

Personalised medicine isn’t a distant vision. With PGx testing, it’s within reach — and Mantara is committed to making it a reality for everyone.

The Challenge

Icon of a medical document with a plus sign on it, inside a teal circle.

Ineffective Prescriptions

Up to 90% of prescription medications are effective in only 30–50% of patients, leading to suboptimal treatment outcomes.

Blue background with a white pound sterling symbol (£) inside a white circle.

Adverse Drug Reactions

Adverse drug reactions account for 1 in 20 occupied hospital beds in the UK and cost the NHS an estimated £2.2 billion each year.

The Solution

Two test tubes in a circular teal background.

Pharmacogenomic (PGx) Testing

PGx testing has been shown to reduce clinically significant adverse drug reactions by approximately 30%, improving patient safety and treatment precision.

NICE Recommends Genetic Testing for Clopidogrel

Around 30% of people have a genetic variant that makes Clopidogrel less effective, which can increase the risk of another stroke. Mantara’s PGx test checks for CYP2C19 variants in line with NICE’s 2024 guidance, helping clinicians choose the safest and most effective treatment for you.

Now Offering: Rapid Clopidogrel
Genetic Test

Mantara now provides a fast CYP2C19 genetic test specifically for people taking Clopidogrel. This quick, focused test gives results within days and helps identify whether the medication is likely to work well for you. It’s a simple way to support safer, more effective protection against stroke and heart attack.

Knowledge is the Best Medicine ™

A personalised approach to treatment can make a real difference, especially if you’ve experienced medicines that haven’t worked well or have caused unwanted side effects. Understanding how your body processes medication is a powerful step toward safer, more effective care.

Our PGx tests can help guide treatment decisions across a wide range of conditions, including high cholesterol, anxiety and depression, acid reflux, and stroke prevention.

A box labeled 'Your PGx DNA Test Kit' with the tagline 'Knowledge is the best medicine'.

Why Mantara?

Mantara Health was founded by doctors who believe every patient deserves truly personalised care. Our mission is to provide high‑quality, evidence‑based DNA testing that helps healthcare professionals make safer, more informed prescribing decisions.

  • Icon with three horizontal lines of increasing length, stacked with a smaller line on top, a medium line in the middle, and a long line at the bottom, all in white on a teal circular background.

    COMPREHENSIVE RESULTS

    Our PGx panel analyses 12 key genes, offering a far more complete picture than tests that only look at one or two. This means clearer insights and more confident treatment decisions.

  • Icon of a shield with a keyhole, representing security or protection.

    DATA PROTECTION

    Your genetic information is handled with the highest level of confidentiality. We protect your data with strict security measures and will never share your results with industry partners.

  • Icon of two capsules, one elongated and one rounded, overlapping each other, on a teal background.

    78 MEDICINES COVERED

    Our test focuses only on medications supported by the strongest, clinically actionable PGx evidence. This ensures that every result you receive is meaningful and relevant to your care.

  • A teal circular icon with a white outline of a ribbon or medal in the center.

    CE & UKCA MARKED

    Our PGx test is approved by the MHRA and carries both CE and UKCA marks, reflecting rigorous quality standards and reliable clinical performance.

WANT TO FIND OUT MORE?

Book a Free 10-Minute Call

A scientist using a microscope in a laboratory.

OR CHECK OUT OUR FAQs!

As Seen In

Text reads 'The Guardian' in black letters
The image displays the phrase 'THE LANC' in black, capitalized letters on a white background.
Black-and-white photograph of a man in a hat and suit standing outdoors in front of an aged building with large windows and multiple signs, including one that says 'No Parking'.

Awards

Red and yellow badge with white text saying 'PING Innovation Award Winner 2023' and the VWV logo.
Banner announcing Medtech and Healthtech StartUp of the Year 2023 award, organized by Startup Awards across North East, Yorkshire, and the Humber, with website www.startupawards.uk.
Logo with stylized purple and pink geometric shapes and the text 'Innovate UK'.

Industry Partners

Close-up of a blue and white DMV vehicle registration sticker with the year 2023.
Logo for the 2026 World Embryo Championship featuring a DNA strand with rainbow colors and text for the event. The logo has a circular design with a green, grey, purple, red, and black color scheme.

Discover How Mantara Can Help You:

Silhouette of a person with medium-length hair, wearing a shirt.

Find out more about the process of PGx testing with Mantara.

Silhouette of a healthcare professional wearing a stethoscope and a cross badge.

Learn about Mantara’s unique, research-backed approach.